Infectious Causes of Acute Cardiac Dysfunction

  • R. E. Cunnion
  • J. E. Parrillo
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 6)


The structural and functional integrity of the heart lie prey to a wide array of infectious troubles. Some cardiac derangements, like infective endocarditis, involve microbes invading directly into cardiac structures; others, like rheumatic carditis, seem to be immune-mediated, associated with infection only as indirect sequelae. Various well-described infectious causes of cardiac dysfunction are classified in Table 1 according to endocardial, myocardial, or pericardial site of involvement; these are widely recognized by clinicians, and they are examined here only briefly, in the final section of this chapter. Instead the emphasis here is upon an infrequently appreciated and incompletely understood, but clinically important, phenomenon: the profound but reversible cardiac dysfunction that accompanies septic shock.


Septic Shock Mean Arterial Pressure Infective Endocarditis Pulmonary Capillary Wedge Pressure Septic Shock Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parker MM, Shelhamer JH, Ognibene FP, et al (1984) Pneumocystis pneumonia and bacterial pneumonia produce similar hemodynamic abnormalities. Clin Res 32: 252AGoogle Scholar
  2. 2.
    Waisbren BA (1951) Bacteremia due to Gram-negative bacilli other than the salmonella. Arch Intern Med 88: 467–488CrossRefGoogle Scholar
  3. 3.
    Udhoji VN, Weil MH (1965) Hemodynamic and metabolic studies on shock associated with bacteremia. Ann Intern Med 62: 966–978PubMedGoogle Scholar
  4. 4.
    Nishijima H, Weil MH, Lubin HS, Cavanilles J (1973) Hemodynamic and metabolic studies on shock associated with Gram-negative bacteremia. Medicine (Baltimore) 52: 287–294CrossRefGoogle Scholar
  5. 5.
    Weil MH, MacLean LD, Visscher MB, Spink WW (1956) Studies on the circulatory changes in the dog produced by endotoxin from Gram-negative microorganisms. J Clin Invest 35: 1191–1198PubMedCrossRefGoogle Scholar
  6. 6.
    Lefer AM (1979) Mechanisms of cardiodepression in endotoxin shock. Circ Shock 1 (suppl): 1–8Google Scholar
  7. 7.
    Wilson RF, Thal AP, Kindling PJH, Grifka T, Ackerman E (1965) Hemodynamic measurements in septic shock. Arch Surg 91: 121–129CrossRefGoogle Scholar
  8. 8.
    MacLean LD, Mulligan WG, McLean APH, Duff JH (1967) Patterns of septic shock in man–a detailed study of 56 patients. Ann Surg 166: 543–562PubMedCrossRefGoogle Scholar
  9. 9.
    Winslow EJ, Loeb HS, Rahimtoola SH, Kamath S, Gunnar RM (1973) Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 54: 421–433PubMedCrossRefGoogle Scholar
  10. 10.
    Clowes GH, Farrington GH, Zuschneid W, Cossette GR, Saravis C (1970) Circulating factors in the etiology of pulmonary insufficiency and right heart failure accompanying severe sepsis (peritonitis). Annals Surg 171: 663–678CrossRefGoogle Scholar
  11. 11.
    Weisel RD, Vito L, Dennis RC, Valeri CR, Hechtman HB (1977) Myocardial depression during sepsis. Am J Surg 133: 512–521PubMedCrossRefGoogle Scholar
  12. 12.
    Parker MM, Shelhamer JH, Bacharach SL, et al (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100: 483–490PubMedGoogle Scholar
  13. 13.
    Wiles JB, Cerra FB, Siegel JR, Border JR (1980) The systemic septic response: does the organism matter? Crit Care Med 8: 55–60PubMedCrossRefGoogle Scholar
  14. 14.
    Calvin JE, Driedger AA, Sibbald WJ (1981) An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest 38: 579–586CrossRefGoogle Scholar
  15. 15.
    Ellrodt AG, Riedlinger MS, Kimchi A, et al (1985) Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J 110: 402–409PubMedCrossRefGoogle Scholar
  16. 16.
    Parker MM, McCarthy KE, Ognibene FP, Parrillo JE (1988) Septic shock in humans produces similar patterns of left and right ventricular dysfunction and dilatation. Clin Res 36 (in press)Google Scholar
  17. 17.
    Ognibene FP, Parker MM, Natanson C, Shelhamer JH, Parrillo JE (1988) Depressed left ventricular performance: response to volume infusion in patients with sepsis and septic shock. Chest 93 (in press)Google Scholar
  18. 18.
    Parker MM, Shelhamer JH, Natanson C, Ailing DW, Parrillo JE (1987) Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15: 923–929PubMedCrossRefGoogle Scholar
  19. 19.
    Natanson C, Fink MP, Balantyne HK, MacVittie TJ, Conklin JJ, Parrillo JE (1986) Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 78: 259–270PubMedCrossRefGoogle Scholar
  20. 20.
    Natanson C, Danner RL, Fink MP, et al (1988) Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am J Physiol 254 (Heart Circ Physiol 23): H558 - H569Google Scholar
  21. 21.
    Reilly JM, Natanson C, Danner RL, et al (1988) Cardiovascular response to volume infusion and catecholamines in a canine model of human septic shock. Clin Res 36 (in press)Google Scholar
  22. 22.
    Natanson C, Danner RL, Akin GL, et al (1988) Antibiotics, fluids and dopamine in a lethal canine model of septic shock: effects of therapy on survival. Clin Res 36 (in press)Google Scholar
  23. 23.
    Natanson C, Cunnion RE, Barrett DA, et al (1986) Reversible myocardial dysfunction in a canine model of septic shock is associated with myocardial microcirculatory damage and focal neutrophil infiltration. Clin Res 34: 639AGoogle Scholar
  24. 24.
    Adiseshiah M, Baird RJ (1978) Correlation of the changes in diastolic myocardial tissue pressure and regional coronary blood flow in hemorrhagic and endotoxic shock. J Surg Res 24: 20–25PubMedCrossRefGoogle Scholar
  25. 25.
    Hinshaw LB, Archer LT, Spitzer JJ, Black MR, Peyton MD, Greenfield LJ (1974) Effects of coronary hypotension and endotoxin on myocardial performance. Am J Physiol 227: 1051–1057PubMedGoogle Scholar
  26. 26.
    Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE (1986) The coronary circulation in human septic shock. Circulation 73: 637–644PubMedCrossRefGoogle Scholar
  27. 27.
    Dhainaut J-F, Huyghebaert M-F, Monsallier JF, et al (1987) Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 75: 533–541PubMedCrossRefGoogle Scholar
  28. 28.
    Lefer AM (1970) Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc 29: 1836–1847PubMedGoogle Scholar
  29. 29.
    Greene LJ, Shapanka R, Glenn TM, Lefer AM (1977) Isolation of myocardial depressant factor from plasma of dogs in hemorrhagic shock. Biochim Biophys Acta 491: 275–285PubMedGoogle Scholar
  30. 30.
    Hinshaw LB (1979) Myocardial function in endotoxin shock. Circ Shock 1 (suppl): 43–51Google Scholar
  31. 31.
    Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W (1985) A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vito myocardial cell performance. J Clin Invest 76: 1539–1553PubMedCrossRefGoogle Scholar
  32. 32.
    Reilly JM, Burch-Whitman C, Parker MM, Shelhamer JH, Weideman M, Parrillo JE (1987) Characteristics of a myocardial depressant substance in patients with septic shock. Circulation 76 (suppl IV): 164Google Scholar
  33. 33.
    Postel J, Schloerb PR (1977) Cardiac depression in bacteremia. Ann Surg 186: 74–82PubMedCrossRefGoogle Scholar
  34. 34.
    Parker MM, Suffredini AF, Natanson C, Ognibene FP, Shelhamer JH, Parrillo JE (1986) Survivors of septic shock in humans develop reversible myocardial depression and ventricular dilatation. Clin Res 34: 413AGoogle Scholar
  35. 35.
    Ognibene FP, Parker MM, Burch-Whitman C, et al (1988) Neutrophil aggregating activity and septic shock in humans: neutrophil aggregation by a C5a-like material occurs more frequently than complement component depletion and correlation with depression of systemic vascular resistance. J Crit Care 3 (in press)Google Scholar
  36. 36.
    Danner RL, Elin RJ, Hosseini JM, Schlesinger T, Reilly JM, Parrillo JE (1988) Endotoxin determinations in 100 patients with septic shock. Clin Res 36 (in press)Google Scholar
  37. 37.
    Natanson C, Danner RL, MacVittie TJ, Walker RI, Conklin JJ, Parrillo JE (1987) Endotoxin administration to dogs simulates the cardiovascular profile of human septic shock. Clin Res 35: 385AGoogle Scholar
  38. 38.
    Suffredini AF, Parker MM, Brenner M, Schlesinger T, Parrillo JE (1987) The cardiovascular effects of intravenous endotoxin in normal human volunteers. Crit Care Med 15: 439CrossRefGoogle Scholar
  39. 39.
    Natanson C, Danner RL, Elin RJ, et al (1988) Cardiovascular dysfunction and lethality in a canine model of human septic shock: E. coli versus S. aureus bacteremia. J Clin Invest 82 (in press)Google Scholar
  40. 40.
    Eichenholz PW, Natanson C, Eichacker, et al (1988) Hemodynamic effects of tumor necrosis factor infusions in conscious dogs. Crit Care Med 16 (in press)Google Scholar
  41. 41.
    Ognibene FP, Rosenberg SA, Skibber J, Shelhamer JH, Lotze MT, Parrillo JE (1986) Interleukin-2 produces hemodynamic changes similar to septic shock in humans. Crit Care Med 14: 352Google Scholar
  42. 42.
    DiNubile MJ (1982) Surgery in active endocarditis. Ann Intern Med 96: 650–659PubMedGoogle Scholar
  43. 43.
    Bowles NE, Richardson PJ, Olsen EGJ, Archard LC (1986) Detection of Coxsackie-Bvirus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1: 1120–1123PubMedCrossRefGoogle Scholar
  44. 44.
    Parrillo JE, Cunnion RE, Epstein SE, et al (1987) Prospective, randomized, controlled trial of anti-inflammatory therapy in dilated cardiomyopathy: a three and nine month follow-up Circulation 76 (suppl IV): 460Google Scholar
  45. 45.
    Cunnion RE, Parrillo JE (1987) Cardiovascular diseases. In: Parrillo JE, Masur H (eds) The critically ill immunosuppressed patient, Aspen Press, Rockville, Maryland, pp 3–38Google Scholar
  46. 46.
    Parker MM et al (1983) Septic shock. J Am Med Assoc 250: 3325Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • R. E. Cunnion
  • J. E. Parrillo

There are no affiliations available

Personalised recommendations